Heather L Rossi1, Ana Recober. 1. Department of Neurology, Perelman School of Medicine, University of Pennsylvania & Children's Hospital of Pennsylvania, Philadelphia, PA, USA.
Abstract
BACKGROUND: Photophobia is a debilitating feature of many headache disorders. OVERVIEW: Clinical and preclinical research has identified several potential pathways involved in enhanced light sensitivity. Some of these structures include trigeminal afferents in the eye, second-order neurons in the trigeminal nucleus caudalis, third-order neurons in the posterior thalamus, modulatory neurons in the hypothalamus, and fourth-order neurons in the visual and somatosensory cortices. It is unclear to what degree each site plays a role in establishing the different temporal patterns of photophobia across different disorders. Peptides such as calcitonin gene-related peptide and pituitary adenylate cyclase-activating polypeptide may play a role in photophobia at multiple levels of the visual and trigeminal pathways. CONCLUSION: While our understanding of photophobia has greatly improved in the last decade, there are still unanswered questions. These answers will help us develop new therapies to provide relief to patients with primary headache disorders.
BACKGROUND:Photophobia is a debilitating feature of many headache disorders. OVERVIEW: Clinical and preclinical research has identified several potential pathways involved in enhanced light sensitivity. Some of these structures include trigeminal afferents in the eye, second-order neurons in the trigeminal nucleus caudalis, third-order neurons in the posterior thalamus, modulatory neurons in the hypothalamus, and fourth-order neurons in the visual and somatosensory cortices. It is unclear to what degree each site plays a role in establishing the different temporal patterns of photophobia across different disorders. Peptides such as calcitonin gene-related peptide and pituitary adenylate cyclase-activating polypeptide may play a role in photophobia at multiple levels of the visual and trigeminal pathways. CONCLUSION: While our understanding of photophobia has greatly improved in the last decade, there are still unanswered questions. These answers will help us develop new therapies to provide relief to patients with primary headache disorders.
Authors: Helena Martín; Margarita Sánchez del Río; Carlos López de Silanes; Juan Álvarez-Linera; Juan Antonio Hernández; Juan A Pareja Journal: Headache Date: 2011 Nov-Dec Impact factor: 5.887
Authors: A Perrotta; M Serrao; G Sandrini; D Bogdanova; C Tassorelli; M Bartolo; G Coppola; F Pierelli; G Nappi Journal: Cephalalgia Date: 2008-07-08 Impact factor: 6.292
Authors: Ana Recober; Adisa Kuburas; Zhongming Zhang; John A Wemmie; Michael G Anderson; Andrew F Russo Journal: J Neurosci Date: 2009-07-08 Impact factor: 6.167
Authors: Mariela C Aguilar; Alex Gonzalez; Cornelis Rowaan; Carolina de Freitas; Karam A Alawa; Heather Durkee; William J Feuer; Fabrice Manns; Shihab S Asfour; Byron L Lam; Jean-Marie A Parel Journal: Biomed Opt Express Date: 2018-10-18 Impact factor: 3.732
Authors: Harrison McAdams; Eric A Kaiser; Aleksandra Igdalova; Edda B Haggerty; Brett Cucchiara; David H Brainard; Geoffrey K Aguirre Journal: Proc Natl Acad Sci U S A Date: 2020-07-06 Impact factor: 11.205